Department of Health and Human Services, through Food and Drug Administration, awarded 28bio, Inc. of Metairie, LA a prime contract with $143,021 obligated so far, with work starting 2026-08-01 and running to 2027-04-30. Each figure links to the federal record.
The contract
| Recipient | 28bio, Inc. (Metairie, LA) |
|---|---|
| Awarding agency | Department of Health and Human Services |
| Awarding office | Food and Drug Administration |
| Amount obligated | $143,021 |
| Period of performance starts | 2026-08-01 |
| Period of performance ends | 2027-04-30 |
| Industry (NAICS) | 541380, Testing laboratories and services |
| Product or service code | B537, Special studies/analysis- medical/health |
| Place of performance | Metairie, Jefferson County, LA |
| How it was competed | Not competed under sap |
| Offers received | 1 |
| Contract type | Purchase order |
| Award number | 75F40126P00150 |
| Recipient registry id (UEI) | RT13MNMRHL33 |
| Business categories | Self-Certified Small Disadvantaged Business, Small Business |
Want the whole picture on 28bio, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on 28bio, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on 28bio, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
8 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
What it is for
Central nervous system (cns)-3D brain organoids neuropharmacological analysis EO 14398
From the federal award record.
Funding actions on this contract
| Date | Action | Modification | Amount |
|---|---|---|---|
| 2026-07-22 | Initial award | 0 | $143,021 |
Every other federal award to 28bio, Inc. on record
The federal register lists 7 other awards to the same registry id, $3,904,960 in all, from 3 agencies.
| Starts | Agency | Amount | Award |
|---|---|---|---|
| 2020-09-09 | National Institutes of Health | $227,946 | Myelinated rodent brain spheroids for high-throughput evaluation of neurotoxicity (R43ES032361) |
| 2019-08-01 | Defense Health Agency | $646,976 | Diseased human motor nerve-on-a-chip as a preclinical model for als (W81XWH1910080) |
| 2018-09-24 | National Institutes of Health | $197,625 | Development of 3D rat nerve-on-a-chip model for chemical toxicity screening (R43ES029886) |
| 2016-07-01 | National Science Foundation | $225,000 | STTR Phase I: Human microphysiological model for assaying the efficacy of drugs for myelin disorders (1622852) |
| 2016-02-01 | National Institutes of Health | $2,083,328 | Peripheral nerve-on-a-chip for predictive preclinical pharmaceutical testing (R42TR001270) |
| 2016-02-01 | National Institutes of Health | $299,226 | Peripheral nerve-on-a-chip for predictive preclinical pharmaceutical testing - project summary the drug develo (SB1TR001270) |
| 2016-02-01 | National Institutes of Health | $224,859 | Peripheral nerve-on-a-chip for predictive preclinical pharmaceutical testing (R41TR001270) |
More on 28bio, Inc.
28bio, Inc.'s funding history and team
Who runs it, who owns it, where the money comes from and what to watch for, every claim linked to its source.
Order Full Report on 28bio, Inc.Look up 28bio, Inc. first. Finding the company and seeing how much is on record uses no credits.
Look up 28bio, Inc.Where this comes from
Federal agencies report every prime contract they sign to the government's register of federal awards: the recipient and its address, the awarding agency and office, the amount obligated, the dates, the industry and product or service codes, where the work is done and how the contract was competed. Contracts to small businesses are marked as such in the same record.
Every figure on this page is taken from the contract's own federal record, linked beside it, as it stood when the page was built. The amount obligated can grow later if the agency adds funding or exercises options on the same contract; the value with all options, where shown, is the most the record says it could reach.